CD59 and Alzheimer disease: Interestingly, we also found levels of endogenous complement regulatory proteins, such as CD59, that binds to the transmembrane residues C8 and C9 and blocks the formation of the MAC [9,10], CD46, and the decay-accelerating factor (DAF), to be low in EVs from AD patients [32].